Longevity Tech and Preventive Care Reshape Wellness Market
OVERVIEW Wellness is fragmenting into two tiers: mass-market fitness tracking and premium longevity medicine. High-net-worth individuals increasingly pursue continuous metabolic monitoring, genetic sequencing, and personalized supplementation protocols rather than generic gym memberships. This reflects a broader wealth-based divergence in healthcare access. KEY SIGNALS Longevity clinics in Manhattan now charge $15K-$50K annually for member programs. Direct-to-consumer biomarker testing (Everlywell, Thorne, InsideTracker) grew 40% YoY. Corporate wellness budgets are shifting from gym stipends toward preventive diagnostics and mental health tech, signaling institutional recognition of longevity ROI. WHAT TO WATCH Monitor regulatory shifts around at-home genetic testing and telemedicine reimbursement—these unlock consumer-grade longevity infrastructure. Watch for acquisition activity in biomarker platforms and which health-tech unicorns achieve profitability. NYC-based founders should track whether insurance players move upmarket to compete on outcomes.
This is a members-only intelligence brief from Yesodi. Join to read the full analysis, discuss with community members, and access all briefs.
Join Yesodi →